New Therapeutic Approaches for Advanced Gastrointestinal Stromal Tumors

Neeta Somaiah, Margaret von Mehren

Research output: Contribution to journalReview articlepeer-review

3 Scopus citations

Abstract

The management of advanced gastronintestinal stromal tumor is increasingly complex because of imatinib refractory disease. Primary resistance to imatinib is uncommon, and most patients progress after development of additional genetic changes. This article reviews management strategies including surgical approaches, local modalities for progressive liver metastases, as well as novel therapeutic agents.

Original languageEnglish (US)
Pages (from-to)139-150
Number of pages12
JournalHematology/Oncology Clinics of North America
Volume23
Issue number1
DOIs
StatePublished - Feb 2009
Externally publishedYes

Keywords

  • Gastrointestinal stromal tumor
  • HSP-90 inhibitors
  • IGF-1R
  • Nilotinib
  • Sorafenib
  • Tyrosine kinase inhibitors

ASJC Scopus subject areas

  • Hematology
  • Oncology

Fingerprint

Dive into the research topics of 'New Therapeutic Approaches for Advanced Gastrointestinal Stromal Tumors'. Together they form a unique fingerprint.

Cite this